Part 1 Basic Information

Name: Wei Wang

Address: School of Pharmacy, Jiangsu University, No. 301 Xuefu Road, Zhenjiang, Jiangsu 212013, China

Email: weiwang@ujs.edu.cn

Part 2 Personal Profile

Dr. Wei Wang is an Associate Professor and Master's Supervisor at the School of Pharmacy, Jiangsu University. Her research focuses on the bioactive material basis of traditional Chinese medicines, as well as toxicity‑attenuation and efficacy‑preservation together with safety evaluation of processed Chinese herbal medicines. She has led 3 national and provincial research projects and published a number of academic papers in peer‑reviewed authoritative journals at home and abroad, including International Immunopharmacology, Toxins, Natural Product Research, China Journal of Chinese Materia Medica and Chinese Journal of Traditional Chinese Medicine. She is the associate editor of a full‑English textbook on Chinese materia medica and has won the Second‑Class Prize of National Commercial Science and Technology Progress Award. She serves as Council Member of the Special Committee for Quality of Processed Chinese Materia Medica under the World Federation of Chinese Medicine Societies, Youth Committee Member of the Chinese Materia Medica Processing Branch of China Association of Chinese Medicine, and Youth Editorial Board Member of Food & Medicine Homology (FMH).

Part 3 Education

•2014.09–2019.06, Nanjing University of Chinese Medicine, Chinese Materia Medica, Ph.D.

•2010.09–2014.06, Nanjing University of Chinese Medicine, Chinese Materia Medica, B.S.

Part 4 Work Experience

•2026.07–Present, School of Pharmacy, Jiangsu University, Associate Professor and Master's Supervisor

•2025.01–2026.07, School of Pharmacy, Jiangsu University, Lecturer and Master's Supervisor

•2019.08–2026.07, School of Pharmacy, Jiangsu University, Lecturer

Part 5 Research Interests

1.Research on the bioactive material basis of traditional Chinese medicines

2.Toxicity attenuation, efficacy preservation and safety evaluation of processed traditional Chinese medicines

3.Pharmacological mechanism of traditional Chinese medicines mediated by the gut microbiota metabolism immune network

Part 6 Research Achievements

6.1 Research Projects

•2025.01–2027.12 | Youth Program of National Natural Science Foundation of China “Material Basis and Mechanism for Enhanced Anti‑COPD Efficacy of Processed Arisaema erubescens via Regulating the ‘Gut Microbiota‑SCFAs/GPCR‑Th17/Treg’ Axis” (Grant No. 82405029) | NSFC | Principal Investigator

•2024.09–2027.08 | General Program of Jiangsu Provincial Natural Science Foundation “Effect and Mechanism of Processed Arisaema erubescens Intervening COPD by Regulating the ‘Gut Microecology‑Metabolism‑Immunity’ Network Guided by the Theory of ‘Lung‑Large Intestine Interior‑Exterior Correlation’” (Grant No. BK20241927) | Jiangsu Provincial Department of Science and Technology | Principal Investigator

•2020.07–2023.06 | Youth Program of Jiangsu Provincial Natural Science Foundation “Correlation Study on Toxicity‑Efficacy Transformation and Degradation Rule of Protein Components for Aconiti Coreani Rhizoma Processed by Replication Method” (Grant No. BK20200907) | Jiangsu Provincial Department of Science and Technology | Principal Investigator

•2022.01–2025.12 | General Program of National Natural Science Foundation of China “Discovery, Analysis and Specific Identification Research of Novel Biomarkers for Hirudo in Chinese Patent Medicines” (Grant No. 82173937) | NSFC | Participant (4th)

6.2 Publications

1.Wang Wei, Shaoqing Zhu, Lin Chu, Yunpeng Zhu, Huan Yang. Investigating the Mechanisms of Suzijiangqi Pill in COPD Intervention through UPLC Q-Exactive Orbitrap MS, Network Pharmacology, and Animal Experiments[J]. Natural Product Research, 2026,40 (12): 3435–3443. （SCI Q3，IF=1.9）

2.Wei Wang, Shaoqing Zhu, Yuanbin Zhang, Lin Chu, Siyao Liu, Huan Yang, Hao Wu. Microbiota, metabolites and mucosal immunity as potential targets of traditional Chinese medicine for respiratory diseases based on the lung‑gut crosstalk[J]. Pharmacological Research ‑ Modern Chinese Medicine, 2024,10:100374.

3.Wei Wang, Lin Chu, Liqun Chen, Rong Yang, Shaoqing Zhu, Yuanbin Zhang, Huan Yang. Authentication of Asini Corii Colla and Taurus Corii Colla based on UPLC‑MS/MS and the discovery of antioxidant peptides associated with the PI3K‑AKT pathway[J]. Natural Product Research, 2023, 37(23): 3971‑3976. （SCI Q3，IF=1.9）

4.Jinfei Li, Wei Wang, Yuan Yuan, Xiaobing Cui, Huimin Bian, Hongmei Wen, Xingde Zhang, Hongli Yu, Hao Wu. Pinellia ternata lectin induces inflammation through TLR4 receptor and mediates PI3K/Akt/mTOR axis to regulate NF‑κB signaling pathway[J]. Toxicology, 2023, 486: 153430. （SCI Q1，IF=4.8）

5.Wei Wang, Shanhu Mao, Hongli Yu, Hao Wu, Xuelian Shan, Xingde Zhang, Guojing Cui, Xianqiong Liu. Pinellia pedatisecta Lectin Exerts a Proinflammatory Activity Correlated with ROS‑MAPKs/NF‑κB Pathways and the NLRP3 Inflammasome in RAW264.7 Cells Accompanied by Cell Pyroptosis[J]. International Immunopharmacology, 2019,66:1‑12. （SCI Q2，IF=3.943）

6.Wei Wang, Hao Wu, Hongli Yu, Xingde Zhang, Guojing Cui, Kuilong Wang, Shanhu Mao, Yaozong Pan. Typhonium giganteum Lectin Exerts A Pro‑Inflammatory Effect on RAW 264.7 via ROS and The NF‑κB Signaling Pathway[J]. Toxins, 2017, 9(9):275. （SCI Q2，IF=3.030）

7.Lin Chu, Shaoqing Zhu, Zixuan Yang, Wei Wang, Huan Yang. Exploration on material basis and mechanism of processed Arisaema erubescens for chronic obstructive pulmonary disease based on animal experiments, UPLC Q‑Exactive Orbitrap MS and network pharmacology[J]. China Journal of Chinese Materia Medica, 2025, 50(7): 1792‑1802. (Chinese Outstanding Leading Journal)

8.Wei Wang, Shaoqing Zhu, Yuanbin Zhang, Man Wang, Lin Chu, Huan Yang, Hongli Yu. Research progress on traditional Chinese medicine regulating lung‑gut mucosal immune system for chronic obstructive pulmonary disease[J]. World Journal of Traditional Chinese Medicine, 2024, 19(20): 3203‑3210.

9.Wei Wang, Shanhu Mao, Xuelian Shan, Ziye Cheng, Yun Chen, Hongli Yu, Hao Wu. Pro‑inflammatory mechanism of Arisaema erubescens lectin based on ROS/NF‑κB signaling pathway and the effect of processing on protein[J]. Chinese Journal of Traditional Chinese Medicine, 2018, 33(5): 1740‑1746.

10.Wei Wang, Kuilong Wang, Xuelian Shan, Ziye Cheng, Yun Chen, Hongli Yu, Hao Wu. Detoxification technologies and common detoxification mechanisms of toxic traditional Chinese medicines[J]. Journal of Nanjing University of Traditional Chinese Medicine, 2017, 33(5): 448‑462.

6.3 Monographs and Textbooks

•Wei Wang (Associate Editor). CHINESE MATERIA MEDICA[M]. Zhenjiang: Jiangsu University Press, 2023. ISBN 978‑7‑5684‑1982‑6.

6.4 Patents and Software Copyrights

•Lian Liu, Jianyu Huang, Hongli Yu, Hao Wu, Kuilong Wang, Wei Wang. A high‑performance liquid chromatography method for the determination of diterpenoid components Prostratin and Pekinenin G in processed Stellera chamaejasme L.: ZL201710196692.5[P]. Granted.

•Wei Wang, Shaoqing Zhu, Lin Chu, Siyao Liu. A method for analyzing anti‑COPD effects of active components from Arisaema erubescens based on network pharmacology and molecular docking: 202310675332.9[P].

•Shaoqing Zhu, Wei Wang, Qiuzhong Shi, Xiang Liu, Jianjun Zhu, Shu Qiu, Chengxue Yi, Li Li, Ping Wang. A subcritical fluid extraction process for Polygonatum rhizome oil: 202410207510.X[P].